Importance: Disruptions in the hospital clinical workforce threaten quality and safety of care and retention of health professionals. It is important to understand which interventions would be well received by clinicians to address the factors associated with turnover. Objectives: To determine well-being and turnover rates of physicians and nurses in hospital practice, and to identify…
JAMA Health Forum Template
Write in a clean editor, then format for JAMA Health Forum in one click — DocuGuru applies the official Clinical & Medical Journals template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the JAMA Health Forum format
JAMA Health Forum is a peer-reviewed journal published by Clinical & Medical Journals, covering Healthcare Policy and Management, Health Systems, Economic Evaluations, Quality of Life, Primary Care and Health Outcomes. Over its lifetime it has published 2,009 papers, which have received 20,934 citations.
| Publisher | Clinical & Medical Journals |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. JAMA Health Forum. 2023;12(3):45–58.
Formats any DOI in JAMA Health Forum style. No sign-up. |
| Publishes research in | Healthcare Policy and Management Health Systems, Economic Evaluations, Quality of Life Primary Care and Health Outcomes Healthcare cost, quality, practices Pharmaceutical Economics and Policy |
| ISSN | 2689-0186 |
| Citation impact (2-yr) | 4.76 |
| h-index | 57 |
| i10-index | 572 |
| Article processing charge | $5,000 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Harvard University |
| Journal website | jamanetwork.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in JAMA Health Forum per year
Citation impact of JAMA Health Forum by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in JAMA Health Forum
Importance: Randomized clinical trials have shown that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) cause significant weight loss and reduce cardiovascular events in patients with type 2 diabetes (T2D). Black patients have a disproportionate burden of obesity and cardiovascular disease and have a higher rate of cardiovascular-related mortality. Racial and ethnic disparities in health outcomes are…
At the start of 2020, the Life Care Center of Kirkland nursing home in Kirkland,
More than 6 million people have died from COVID-19 worldwide, including nearly 1 million in the US.1 But mortality is not the only adverse consequence of COVID-19. Many survivors suffer long-term impairment, officially termed postacute sequelae of SARS-CoV-2 infection and commonly called long COVID.
The landscape of the coronavirus disease 2019 (COVID-19) pandemic is rapidly changing, with new hot spots of concentrated coronavirus infections emerging across the US and around the world.